FOXO TECHNOLOGIES INC. Cash and Cash Equivalents, Period Increase (Decrease)
FOXO TECHNOLOGIES INC. (FOXO) reported Cash and Cash Equivalents, Period Increase (Decrease) of -$779.31 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-07.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2022-03-07
- FOXO TECHNOLOGIES INC. cash and cash equivalents, period increase (decrease) for fiscal 2021 was -$779.31K.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 8 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month |
|---|---|---|
| 2021-12-31 | -$779.31K 10-K · filed 2022-03-07 | |
| 2020-12-31 | $1.42M 10-K · filed 2022-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |